|
Sign In to gain access to subscriptions and/or personal tools.
|
Full-mouth Tooth Extraction Lowers Systemic Inflammatory and Thrombotic Markers of Cardiovascular Risk
B.A. Taylor1,*,
G.H. Tofler2,
H.M.R. Carey1,
M.-C. Morel-Kopp2,
S. Philcox2,
T.R. Carter1,
M.J. Elliott1,
A.D. Kull2,
C. Ward2 and
K. Schenck3
1 Sydney Dental Hospital, 2 Chalmers Street, Surry Hills NSW 2010, Australia;
2 Royal North Shore Hospital, New South Wales, Australia; and
3 Department of Oral Biology, University of Oslo, Norway
Correspondence: * corresponding author, barbara.taylor{at}email.cs.nsw.gov.au
 |
ABSTRACT
|
|---|
Prior studies of a link between periodontal and cardiovascular disease have been limited by being predominantly observational. We used a treatment intervention model to study the relationship between periodontitis and systemic inflammatory and thrombotic cardiovascular indicators of risk. We studied 67 adults with advanced periodontitis requiring full-mouth tooth extraction. Blood samples were obtained: (1) at initial presentation, immediately prior to treatment of presenting symptoms; (2) one to two weeks later, before all teeth were removed; and (3) 12 weeks after full-mouth tooth extraction. After full-mouth tooth extraction, there was a significant decrease in C-reactive protein, plasminogen activator inhibitor-1 and fibrinogen, and white cell and platelet counts. This study shows that elimination of advanced periodontitis by full-mouth tooth extraction reduces systemic inflammatory and thrombotic markers of cardiovascular risk. Analysis of the data supports the hypothesis that treatment of periodontal disease may lower cardiovascular risk, and provides a rationale for further randomized studies.
Key Words: periodontal disease cardiovascular disease
 |
INTRODUCTION
|
|---|
Periodontal disease, the most common chronic infection in humans, is caused by pathogenic bacteria that colonize as oral biofilms. Periodontitis, its severe form, affects approximately 15–20% of dentate adults in Australia (Barnard, 1993) and induces chronic inflammation and immune reactions that result in the loss of the bone and soft tissues that support the teeth in the jaws.
Observational studies show that periodontitis is associated with an increased risk of myocardial infarction and stroke, although a causal link has not yet been proven (Scannapieco et al., 2003). The effect may be due to the direct action of periodontal pathogens or their products on endothelial cells via transient bacteremia (Geerts et al., 2002) or indirectly via products of the inflammatory response (Choi et al., 2002), since inflammation is currently considered to play a central role in the pathogenesis of cardiovascular disease (CVD) (Ridker et al., 2004).
While several case-control and cohort studies have indicated an association between periodontitis and CVD (Mattila et al., 1989; DeStefano et al., 1993; Beck et al., 1996), not all studies have found a significant association (Hujoel et al., 2000; Mattila et al., 2000; Howell et al., 2001). A limitation of observational studies is that traditional risk factors, such as age, cigarette smoking, and diabetes, are common to both periodontitis and CVD. Furthermore, both conditions are influenced by factors such as level of education, income, psychosocial stress, and social isolation (Hujoel et al., 2000). Thus, although significant associations persist after adjustment for known confounders, there remains the possibility that they primarily show that people who are more health-conscious and have better access to health care are at lower risk of both CVD and periodontitis.
Establishing whether or not there is a causal link between periodontitis and CVD is important for several reasons. First, it fits with current thinking about atherosclerosis as an inflammatory disorder. Second, it would suggest that cardiovascular risk assessment should include a periodontal evaluation. Third, demonstration of causality would suggest that prevention and treatment of periodontitis could reduce CVD. The purpose of this study was to investigate whether elimination of periodontitis by full-mouth tooth extraction (FME) reduces levels of known hemostatic indicators of risk.
 |
METHODS
|
|---|
Study Group
The target population for the study was adults over 40 yrs of age who presented to the Sydney Dental Hospital with advanced periodontitis. Each patient had at least 2 teeth with periodontal pockets of 6 mm in conjunction with attachment loss and bleeding on probing. The patients were examined by hospital clinicians independent of the study. If FME was the recommended treatment, and there were no general health complaints or symptoms consistent with active systemic inflammation or infection, the patients were invited to participate in the study.
Study Design
The model chosen was a longitudinal cohort study with observations made before and after treatment of advanced periodontitis in cases where FME was indicated. Tooth extraction is an absolute treatment for the disease, because without teeth there cannot be any periodontitis. A limitation is that we did not have a matched control group. However, the design could not be randomized, because allocation of patients to experimental and control groups would have delayed treatment of advanced periodontitis for several months for some patients. This was considered to be unethical and unlikely to be accepted by the patients. A convenience sample of 76 subjects was enrolled, of whom 67 completed the study.
At the initial visit, 27 of the patients presented with loose teeth, 17 presented with pain triggered by chewing with loose teeth or by lacerating the tongue, lips, or opposing ridge with the sharp edges of teeth, six patients presented with the request for extraction of all of their remaining teeth, and 17 presented with various other symptoms. Fifty-two persons had one or more extractions on the day of the initial visit, and one patient with a dry socket received a seven-day course of amoxycillin. The medical history of the participants was recorded. The history focused on cardiovascular risk factors, including diabetes mellitus, hypertension, hyperlipidemia, smoking, and any history of cardiac, cerebral, or peripheral vascular disease. The medical examination included the patients height, weight, temperature, blood pressure, heart rate, and ECG recording. The dental examination included charting of probing pocket depth and recession at 6 sites around each tooth. The sums and averages of probing pocket depths and recession were calculated for each participant.
Most extractions (42) were completed within 1 to 4 wks of initial presentation. Another 15 persons had all their teeth extracted between 4 and 8 wks after presentation, and a further ten persons took more than 8 wks to complete extractions. All participants completed FME within 14 wks. Approximately 3 mos after FME, the medical history was repeated and a medical examination performed. An oral examination was conducted at the same time, mainly to confirm the absence of teeth, tooth fragments, or oral ulceration.
The study was approved by the Ethics Review Committee of the Sydney Dental Hospital, and written informed consent was obtained from all study participants.
Blood Sampling and Hemostatic Analyses
Peripheral blood samples were obtained at 3 timepoints. Timepoint 1 (T1) was on the day of presentation to the hospital, prior to relief of presenting symptoms. Timepoint 2 (T2) was approximately 1 to 2 wks after acute treatment, when chronic periodontitis was still present. Timepoint 3 (T3) was approximately 12 wks after all the teeth had been extracted. A total of 30 mL of blood was drawn at each timepoint, by a standard venipuncture technique. Blood samples were taken between 0900 and 1130 hrs. Blood samples were collected in tubes containing 3.8% sodium citrate for C-reactive protein (CRP), fibrinogen, plasminogen activator inhibitor antigen (PAI-1), and tissue plasminogen activator antigen (TPA). Samples were then centrifuged, and plasma was collected and frozen at –70°C until analysis. Plasma fibrinogen was determined according to the Clauss Method (Clauss, 1957). PAI-1 and TPA were measured by commercial enzyme-linked immunosorbent assays (ELISA) (Imulyse tPA and Imulyse PAI-1, Biopool International, Ventura, CA, USA). CRP was measured by high-sensitivity ELISA (UBI Magiwel, CRP Enzyme Immunoassay, United Biotech Inc., Mountain View, CA, USA). In the last 39 patients recruited, blood was also collected for analysis of white cell and differential counts, platelets, hemoglobin, urea and electrolytes, glucose, and cholesterol measurement.
Statistical Evaluation
Associations between clinical dental registrations and blood values at the outset of the study were sought by calculation of the Spearman correlation. Hematological markers were compared before and after treatment with paired t tests. When needed, individual values were log-transformed to comply with criteria for normality and equality of variances of groups. When these criteria could not be fulfilled by any mathematical transformation, Wilcoxon signed-rank tests were used. Data are presented as means ± standard deviations when normally distributed, and as medians ± 25–75% confidence intervals when not normally distributed. Associations between pre- and post-treatment blood values were sought by calculation of Spearman correlation coefficients. We performed an additional analysis excluding the first timepoint of the subject who received amoxycillin at T1. This did not alter the statistical significances observed.
 |
RESULTS
|
|---|
Seventy-seven persons were initially enrolled, and 67 completed the study. Three persons withdrew consent because they decided not to proceed with treatment. One had FME at T1, and another was found to have disseminated cancer. Four persons dropped out after the T2 visit, and one dropped out after the T1 visit.
The characteristics of the 67 persons who completed the study are shown in Table 1 . Since the study could not be randomized, we took special care to evaluate whether there were any significant changes in the patients medical condition from baseline to conclusion of the study. Specifically, weight, blood pressure, and smoking habits did not change significantly in any of the participants during the course of the study. None of the patients reported illnesses such as infection, inflammatory disease, or myocardial infarct that could have affected the levels of the experimental variables. There were no significant differences between the ECG recordings made for each person at T2 and those at T3.
The mean levels of risk indicators before and after periodontal treatment are shown in Table 2 . There were no significant differences between levels of the markers at T1 and T2. CRP levels fell significantly from T1 to T3 and from T2 to T3. PAI-1 levels fell significantly from T1 to T3. Values for TPA and fibrinogen also showed a downward trend from T1 to T3, although this was not significant. Fibrinogen values decreased significantly from T2 to T3.
View this table:
[in this window]
[in a new window]
|
Table 2. Effect of FME on Inflammatory and Thrombotic Risk Markers [Pre-(T1 and T2) and Post-(T3)treatment Levels of CRP, PAI-1, TPA, and Fibrinogen; Means (SD)a]
|
|
Total white blood cell count, neutrophils, lymphocytes, and platelets displayed a significant reduction after tooth extraction (Table 3 ). Hemoglobin levels and red blood cell counts showed significant increases after FME (Table 3 ). By contrast, glycosylated hemoglobin, urea, electrolytes, glucose, and cholesterol measurement did not change significantly during the observation period (data not shown).
View this table:
[in this window]
[in a new window]
|
Table 3. Effect of FME on Blood Cell Counts. Pre- and Post-treatment Counts of Total White Blood Cells, Neutrophils, Lymphocytes, and Red Blood Cells (Median, 25–75%), and Hemoglobin and Platelet Counts (mean, SD)a
|
|
Prevalence and severity of periodontitis are higher in smokers than in non-smokers (Kerdvongbundit and Wikesjö, 2002). The data were therefore analyzed according to smoking status. Non-smokers were defined as persons who had never smoked or who had given up smoking prior to the study, while smokers were those who smoked during the study. None of the study participants changed his/her smoking habits during the course of the study. Similar downward trends in inflammatory and hemostatic markers were seen for both non-smokers and smokers. Variables that showed significant differences from T1 to T3 are displayed in Table 4 . The magnitudes of change were greater among the non-smokers, and significant reductions were seen in CRP, white blood cells, neutrophils, lymphocytes, and platelets after FME in the non-smoking group only.
Associations at the outset of the study—between sums and averages of probing pocket depths and recession, and between inflammatory and cardiovascular risk indicators—were examined. No statistically significant correlations were found between clinical variables (number of teeth, age, and sum of PPD) and laboratory measurements (Spearman correlation coefficients, p > 0.05), with the exception of mean periodontal pocket depth, which was found to be inversely associated with hematocrit values (rs = –0.342, p < 0.05).
 |
DISCUSSION
|
|---|
The present study shows that blood levels of CRP, PAI-1, and fibrinogen, established indicators of risk for CVD, are reduced in patients with severe periodontitis after extraction of all teeth. Even though the number of teeth was limited prior to FME (Table 1 ), and therefore the infected periodontal surface area was not particularly large, FME resulted in a significant reduction in several of the parameters examined. An important recent advance in the understanding of the pathogenesis of CVD has been recognition of the role of inflammation and thrombosis in atherosclerosis and acute coronary syndromes (Ridker et al., 2004). Inflammatory cells have been shown to play an important role in the thinning and weakening of the cap overlying atherosclerotic plaques. Whether thrombosis occurs following plaque disruption depends on a complex balance of factors, including PAI-1, TPA, and fibrinogen. PAI-1, the major antifibrinolytic, and TPA are mainly produced in endothelium and platelets. TPA forms inactive complexes with PAI-1 in the blood and tissues. Higher levels of TPA antigen therefore reflect impaired fibrinolytic potential. Increased levels of fibrinogen result in its binding to platelets, causing platelet aggregation and promotion of fibrin formation, thus contributing to plasma viscosity. Epidemiological studies have shown that increased levels of CRP, fibrinogen, and PAI-1 are strong predictors of CVD (Hamsten et al., 1987; Jadhav and Tofler, 1996). Hepatic production of CRP, a strong acute-phase protein, is induced by pro-inflammatory cytokines in response to tissue injury and infection, both of which occur in periodontitis (Loos et al., 2000).
Chronic infections are known to be associated with the development of CVD. Microbes can directly damage the endothelium, as has been shown for cytomegalovirus and Helicobacter pylori (Grau et al., 1995; Libby et al., 1997). Periodontal pathogens have been found in atheromas from patients with severe periodontitis, and periodontopathogenic bacteria such as Porphyromonas gingivalis can adhere to and invade endothelial cells (Li et al., 2000). Microbial infection may induce the release of pro-inflammatory cytokines that increase levels of CRP, fibrinogen, and PAI-1, the same molecules that are recognized indicators of risk for CVD.
Cross-sectional studies have demonstrated that plasma levels of inflammatory markers such as CRP, fibrinogen, von Willebrand factor, interleukin-6, and leukocyte counts are increased in patients with periodontal disease, in comparison with periodontally healthy patients (Shklair et al., 1968; Fey and Fuller, 1987; Tatakis, 1992; Kweider et al., 1993; Ebersole et al., 1997; Loos et al., 2000; Slade et al., 2000). In less severe periodontitis, reduction in levels of interleukin-1 and CRP have also been reported after periodontal treatment (DAiuto et al., 2004). This indicates that the inflammatory response to periodontitis contributes to the whole-body inflammatory burden.
It has been shown that persons with chronic periodontitis display signs of a subclinical systemic inflammatory condition (Ebersole et al., 1997). The results of the present study support this notion: Counts of white cells, neutrophils, and lymphocytes, which are systemic markers of inflammation, were reduced after FME in the current patients. Platelets have their main function in hemostasis, but they also play a role in inflammatory processes, and their numbers increase in chronic inflammation (Klinger and Jelkmann, 2002). In this study, the number of platelets decreased after treatment. In sum, the present results show that the presence of untreated periodontitis has systemic inflammatory effects.
Periodontitis has been reported to be associated with signs of "anemia of chronic disease", as expressed by lower hematocrit, lower numbers of erythrocytes, and lower hemoglobin levels (Hutter et al., 2001). The presently detected inverse correlation between hematocrit and mean periodontal pocket depth suggests that this too is related to periodontitis severity. We furthermore found a significant increase in hemoglobin after treatment, indicating that the mildly anemic condition in periodontal patients is likely to be due to the presence of periodontitis.
Smoking is a major confounding factor for studies of cardiovascular and periodontal diseases, both of which have been shown to be associated with increased CRP levels and increased white blood cell counts (Kweider et al., 1993; Fredriksson et al., 1999). We analyzed our data according to smoking status. Downward trends in inflammatory and cardiovascular risk indicators were observed in both smoking and non-smoking groups, but they were more pronounced in the non-smoking group, where several significant differences before and after treatment were found. By contrast, the differences were smaller and lost statistical significance in the smoking group (with the exception of the platelet count, which increased).
In summary, treatment of advanced periodontitis by FME reduced systemic levels of hemostatic indicators of cardiovascular risk and inflammatory mediators. This means that induction of a systemic inflammatory and prothrombotic state may be a mechanism by which chronic periodontitis increases the risk of myocardial infarction and stroke. The findings suggest that treatment of periodontitis may reduce the risk of cardiovascular disease. FME is a severe treatment and not suitable for most patients. Future studies will have to determine if other oral interventions, such as more limited periodontal treatment for less severe disease, can also reduce systemic levels of the inflammatory and thrombotic risk factors.
 |
ACKNOWLEDGMENTS
|
|---|
This study was supported by the Sydney Dental Hospital, the Royal North Shore Hospital, and the University of Oslo. The authors thank the staff and patients of the Sydney Dental Hospital for their assistance.
Received for publication February 8, 2005.
Revision received May 5, 2005.
Accepted for publication August 5, 2005.
 |
REFERENCES
|
|---|
- Barnard PD (1993). National Oral Health Survey Australia 1987–88. Department of Health, Housing, Local Government & Community Services, Canberra: Australian Government Publishing Service.
- Beck J, Garcia R, Heiss G, Vokonas PS, Offenbacher S (1996). Periodontal disease and cardiovascular disease. J Periodontol 67:1123–1137.[Medline]
[Order article via Infotrieve]
- Choi JI, Chung SW, Kang HS, Rhim BY, Kim SJ, Kim SJ (2002). Establishment of Porphyromonas gingivalis heat-shock-protein-specific T-cell lines from atherosclerosis patients. J Dent Res 81:344–348.
- Clauss A (1957). Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens [Rapid physiological coagulation method in determination of fibrinogen]. Acta Haematol 17:237–246.[Medline]
[Order article via Infotrieve]
- DAiuto F, Ready D, Tonetti MS (2004). Periodontal disease and C-reactive protein-associated cardiovascular risk. J Periodontol Res 39:236–241.[CrossRef][Medline]
[Order article via Infotrieve]
- DeStefano F, Anda RF, Kahn HS, Williamson DF, Russell CM (1993). Dental disease and risk of coronary heart disease and mortality. BMJ 306:688–691.[Abstract/Free Full Text]
- Ebersole JL, Machen RL, Steffen MJ, Willmann DE (1997). Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitis. Clin Exp Immunol 107:347–352.[CrossRef][Medline]
[Order article via Infotrieve]
- Fey GH, Fuller GM (1987). Regulation of acute phase gene expression by inflammatory mediators. Mol Biol Med 4:323–338.[Medline]
[Order article via Infotrieve]
- Fredriksson MI, Figueredo CM, Gustafsson A, Bergström KG, Åsman BE (1999). Effect of periodontitis and smoking on blood leukocytes and acute-phase proteins. J Periodontol 70:1355–1360.[CrossRef][Medline]
[Order article via Infotrieve]
- Geerts SO, Nys M, De MP, Charpentier J, Albert A, Legrand V, et al. (2002). Systemic release of endotoxins induced by gentle mastication: association with periodontitis severity. J Periodontol 73:73–78.[CrossRef][Medline]
[Order article via Infotrieve]
- Grau AJ, Buggle F, Heindl S, Steichen-Wiehn C, Banerjee T, Maiwald M, et al. (1995). Recent infection as a risk factor for cerebrovascular ischemia. Stroke 26:373–379.[Abstract/Free Full Text]
- Hamsten A, deFaire U, Walldius G, Dahlén G, Szamosi A, Landou C, et al. (1987). Plasminogen activator inhibitor in plasma: a risk factor for recurrent myocardial infarction. Lancet 2:3–9.[CrossRef][Medline]
[Order article via Infotrieve]
- Howell TH, Ridker PM, Ajani UA, Hennekens CH, Christen WG (2001). Periodontal disease and the risk of subsequent cardiovascular disease in US male physicians. J Am Coll Cardiol 37:445–450.[Abstract/Free Full Text]
- Hujoel PP, Drangsholt M, Spiekerman C, DeRouen TA (2000). Periodontal disease and coronary heart disease risk. J Am Med Assoc 284:1406–1410.[Abstract/Free Full Text]
- Hutter JW, van der Velden U, Varoufaki A, Huffels RA, Hoek FJ, Loos BG (2001). Lower numbers of erythrocytes and lower levels of hemoglobin in periodontitis patients compared to control subjects. J Clin Periodontol 28:930–936.[Medline]
[Order article via Infotrieve]
- Jadhav PP, Tofler GH (1996). Hemostatic risk factors for cardiovascular disease In: Triggering of acute coronary syndromes: implications for prevention. Willich SN, Muller JE, editors. Dordrecht: Kluwer Academic Publishers, pp. 135 151.
- Kerdvongbundit V, Wikesjö UM (2002). Prevalence and severity of periodontal disease at mandibular molar teeth in smokers with regular oral hygiene habits. J Periodontol 73:735–740.[Medline]
[Order article via Infotrieve]
- Klinger MH, Jelkmann W (2002). Role of blood platelets in infection and inflammation. J Interferon Cytokine Res 22:913–922.[CrossRef][Medline]
[Order article via Infotrieve]
- Kweider M, Lowe GD, Murray GD, Kinane DF, McGowan DA (1993). Dental disease, fibrinogen and white cell count; links with myocardial infarction? Scott Med J 38:73–74.[Medline]
[Order article via Infotrieve]
- Li X, Kolltveit KM, Tronstad L, Olsen I (2000). Systemic diseases caused by oral infection. Clin Microbiol Rev 13:547–558.[Abstract/Free Full Text]
- Libby P, Egan D, Skarlatos S (1997). Role of infectious agents in atherosclerosis and restenosis: an assessment of the evidence and need for future research. Circulation 96:4095 4103.
- Loos BG, Craandijk J, Hoek FJ, Wertheim-van Dillen PM, van der Velden U (2000). Elevation of systemic markers related to cardiovascular diseases in the peripheral blood of periodontitis patients. J Periodontol 71:1528–1534.[CrossRef][Medline]
[Order article via Infotrieve]
- Mattila KJ, Nieminen MS, Valtonen VV, Rasi VP, Kesaniemi YA, Syrjala SL, et al. (1989). Association between dental health and acute myocardial infarction [see comments]. BMJ 298:779–781; comments in BMJ 298:1579–1580.[Free Full Text]
- Mattila KJ, Asikainen S, Wolf J, Jousimies-Somer H, Valtonen V, Nieminen M (2000). Age, dental infections, and coronary heart disease. J Dent Res 79:756–760.
- Ridker PM, Brown NJ, Vaughan DE, Harrison DG, Mehta JL (2004). Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 109(25 Suppl 1):IV6–IV19.[Medline]
[Order article via Infotrieve]
- Scannapieco FA, Bush RB, Paju S (2003). Associations between periodontal disease and risk for atherosclerosis, cardiovascular disease, and stroke. A systematic review. Ann Periodontol 8:38–53.[CrossRef][Medline]
[Order article via Infotrieve]
- Shklair IL, Loving RH, Leberman OF, Rau CF (1968). C-Reactive protein and periodontal disease. J Periodontol 37:93–95.
- Slade GD, Offenbacher S, Beck JD, Heiss G, Pankow JS (2000). Acute-phase inflammatory response to periodontal disease in the US population. J Dent Res 79:49–57.
- Tatakis DN (1992). Blood coagulation factors in periodontal pathophysiology. A review with emphasis on the role of thrombin. Semin Thromb Hemost 18:28–33.[Medline]
[Order article via Infotrieve]
Journal of Dental Research, Vol. 85, No. 1,
74-78 (2006)
DOI: 10.1177/154405910608500113

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
F. D'Aiuto, W. Sabbah, G. Netuveli, N. Donos, A. D. Hingorani, J. Deanfield, and G. Tsakos
Association of the Metabolic Syndrome with Severe Periodontitis in a Large U.S. Population-Based Survey
J. Clin. Endocrinol. Metab.,
October 1, 2008;
93(10):
3989 - 3994.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Dietrich, M. Jimenez, E. A. Krall Kaye, P. S. Vokonas, and R. I. Garcia
Age-Dependent Associations Between Chronic Periodontitis/Edentulism and Risk of Coronary Heart Disease
Circulation,
April 1, 2008;
117(13):
1668 - 1674.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Wu, B. L. Plassman, J. Liang, and L. Wei
Cognitive Function and Dental Care Utilization Among Community-Dwelling Older Adults
Am J Public Health,
December 1, 2007;
97(12):
2216 - 2221.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. A. Shultis, E. J. Weil, H. C. Looker, J. M. Curtis, M. Shlossman, R. J. Genco, W. C. Knowler, and R. G. Nelson
Effect of Periodontitis on Overt Nephropathy and End-Stage Renal Disease in Type 2 Diabetes
Diabetes Care,
February 1, 2007;
30(2):
306 - 311.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|